These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 377716)

  • 1. Augmentation of cell-mediated cytotoxicity by short-term in vitro precultivation of effector cells.
    Steinmuller D; Santee LJ; Krco CJ
    Transplant Proc; 1979 Mar; 11(1):834-6. PubMed ID: 377716
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of niridazole in cellular immunity in vivo and in vitro.
    Solbach W; Wagner H; Röllinghoff M
    Clin Exp Immunol; 1978 Jun; 32(3):411-8. PubMed ID: 357051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoblast-mediated nonspecific suppression of alloantigen-induced cytotoxicity.
    Ferguson RM; Simmons RL
    Transplant Proc; 1979 Mar; 11(1):910-3. PubMed ID: 452108
    [No Abstract]   [Full Text] [Related]  

  • 4. [In vitro comparison of 2 expressions of cellular immunity induced by a cutaneous allograft in the mouse].
    Degiovanni G
    C R Seances Soc Biol Fil; 1975; 169(3):724-9. PubMed ID: 129224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells.
    Wright SC; Bonavida B
    J Immunol; 1982 Jul; 129(1):433-9. PubMed ID: 7086139
    [No Abstract]   [Full Text] [Related]  

  • 6. T cell responses to alloantigens. I. Studies of in vivo and in vitro immunologic memory and suppression by limit dilution analysis.
    Burton RC; Fortin JL; Russell PS
    J Immunol; 1980 Jun; 124(6):2936-43. PubMed ID: 6154743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Augmentation of in vitro generation of cytotoxic lymphocytes by priming the donor of responder cells with alloantigens. Possibility of multi-receptor (author's transl)].
    Yamada H
    Fukuoka Igaku Zasshi; 1977 Aug; 68(8):377-96. PubMed ID: 303214
    [No Abstract]   [Full Text] [Related]  

  • 8. Requlation of cytotoxic lymphocyte responses in New Zealand mice by alloantigen-activated spleen cells.
    Huston DP; Rich RR; Steinberg AD; Truitt GA
    J Immunol; 1979 Apr; 122(4):1476-81. PubMed ID: 448096
    [No Abstract]   [Full Text] [Related]  

  • 9. Modulation of cell-mediated alloimmunity by BCG. II. Induction of specific, nonadherent, non-T-killer cells by BCG and alloantigen.
    Murahata RI; Mitchell MS
    J Natl Cancer Inst; 1982 Sep; 69(3):613-8. PubMed ID: 6810008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation.
    Begovic M; Herberman R; Gorelik E
    Cancer Res; 1991 Oct; 51(19):5153-9. PubMed ID: 1913641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic inhibition in tolerant animals.
    Möller E; Lapp W; Lindholm L
    Transplant Proc; 1969 Mar; 1(1):543-7. PubMed ID: 4944269
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective immunosuppression by drugs in balanced immune responses.
    Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
    Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. III. Epidermal cell-specific cytotoxic T lymphocytes.
    Tyler JD; Steinmuller D
    J Immunol; 1981 May; 126(5):1759-63. PubMed ID: 7012238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
    Rouse BT; Wagner H; Harris AW
    J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. II. Genetic basis of the response of C3H mice.
    Steinmuller D; Tyler JD; David CS
    J Immunol; 1981 May; 126(5):1754-8. PubMed ID: 7217663
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukemia virus-induced immunosuppression. 8. Rapid depression of in vitro leukocyte migration after infection of mice with Friend leukemia virus.
    Friedman H; Ceglowski WS
    J Immunol; 1971 Dec; 107(6):1673-81. PubMed ID: 5000989
    [No Abstract]   [Full Text] [Related]  

  • 17. Broadly reactive murine cytotoxic cells induced in vitro under syngeneic conditions.
    Dorfman N; Winkler D; Burton RC; Kossayda N; Sabia P; Wunderlich J
    J Immunol; 1982 Oct; 129(4):1762-8. PubMed ID: 6213719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cell-mediated alloimmunity by BCG. I. Antagonism and potentiation of immunosuppression caused by cytarabine.
    Murahata RI; Mitchell MS
    J Natl Cancer Inst; 1982 Sep; 69(3):607-12. PubMed ID: 6981020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro manifestations of cellular and humoral allograft and anti-tumor immunity: no appreciable alteration by previous storage of targe and effector cells in liquid nitrogen.
    Jeejeebhoy HF; Lawler EM
    J Reticuloendothel Soc; 1976 Apr; 19(4):211-9. PubMed ID: 775083
    [No Abstract]   [Full Text] [Related]  

  • 20. Concordant xenoreactive and alloreactive cell-mediated immune responses are relatively comparable.
    Rehman A; Tu Y; Walp L; Flye MW
    Transplant Proc; 1996 Apr; 28(2):658-9. PubMed ID: 8623330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.